Guidance toward the implementation of multicriteria decision analysis framework in developing countries

András Inotai, Huong Thanh Nguyen, Budi Hidayat, Talgat Nurgozhin, Pham Huy Tuan Kiet, Jonathan D. Campbell, Bertalan Németh, Nikos Maniadakis, Diana Brixner, Kalman Wijaya, Zoltán Kaló

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    Introduction: Multiple Criteria Decision Analysis (MCDA) is increasingly used in health care mainly because it moves decision-making from ad hoc to an evidence-based and comprehensive process. Developing countries with more restricted financial and human research capacities, however, should consider their own methods of MCDA development and implementation. Areas covered: An MCDA framework to improve procurement decisions of off-patent pharmaceuticals was developed for developing countries and adapted to Indonesia, Kazakhstan and Vietnam during three policy workshops. Based on the experience of these workshops and one joint workshop with international experts and decision makers from multiple developing countries, general recommendations were formulated on how to implement MCDA specifically in developing countries. We provide 17 practical MCDA implementation recommendations in four major areas, including (1) MCDA objectives; (2) technical considerations of MCDA tool; (3) development and customization of MCDA tool and (4) policy implementation of MCDA in decision-making. Expert commentary: These practical MCDA recommendations for developing countries contribute to feasible, transparent, stepwise, iterative and standardized decision-making in health care.

    Original languageEnglish
    Pages (from-to)585-592
    Number of pages8
    JournalExpert Review of Pharmacoeconomics and Outcomes Research
    Volume18
    Issue number6
    DOIs
    Publication statusPublished - Nov 2 2018

    Fingerprint

    Decision Support Techniques
    Developing Countries
    Decision Making
    Education
    Kazakhstan
    Delivery of Health Care
    Indonesia
    Vietnam
    Developed Countries

    Keywords

    • Decision Making
    • Developing Countries
    • Implementation Guidance
    • Multiple Criteria Decision Analysis
    • Off-patent Pharmaceuticals

    ASJC Scopus subject areas

    • Health Policy
    • Pharmacology (medical)

    Cite this

    Guidance toward the implementation of multicriteria decision analysis framework in developing countries. / Inotai, András; Nguyen, Huong Thanh; Hidayat, Budi; Nurgozhin, Talgat; Kiet, Pham Huy Tuan; Campbell, Jonathan D.; Németh, Bertalan; Maniadakis, Nikos; Brixner, Diana; Wijaya, Kalman; Kaló, Zoltán.

    In: Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 18, No. 6, 02.11.2018, p. 585-592.

    Research output: Contribution to journalArticle

    Inotai, A, Nguyen, HT, Hidayat, B, Nurgozhin, T, Kiet, PHT, Campbell, JD, Németh, B, Maniadakis, N, Brixner, D, Wijaya, K & Kaló, Z 2018, 'Guidance toward the implementation of multicriteria decision analysis framework in developing countries', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 18, no. 6, pp. 585-592. https://doi.org/10.1080/14737167.2018.1508345
    Inotai, András ; Nguyen, Huong Thanh ; Hidayat, Budi ; Nurgozhin, Talgat ; Kiet, Pham Huy Tuan ; Campbell, Jonathan D. ; Németh, Bertalan ; Maniadakis, Nikos ; Brixner, Diana ; Wijaya, Kalman ; Kaló, Zoltán. / Guidance toward the implementation of multicriteria decision analysis framework in developing countries. In: Expert Review of Pharmacoeconomics and Outcomes Research. 2018 ; Vol. 18, No. 6. pp. 585-592.
    @article{8a602f630bfb4e6a828ec3873fc8b668,
    title = "Guidance toward the implementation of multicriteria decision analysis framework in developing countries",
    abstract = "Introduction: Multiple Criteria Decision Analysis (MCDA) is increasingly used in health care mainly because it moves decision-making from ad hoc to an evidence-based and comprehensive process. Developing countries with more restricted financial and human research capacities, however, should consider their own methods of MCDA development and implementation. Areas covered: An MCDA framework to improve procurement decisions of off-patent pharmaceuticals was developed for developing countries and adapted to Indonesia, Kazakhstan and Vietnam during three policy workshops. Based on the experience of these workshops and one joint workshop with international experts and decision makers from multiple developing countries, general recommendations were formulated on how to implement MCDA specifically in developing countries. We provide 17 practical MCDA implementation recommendations in four major areas, including (1) MCDA objectives; (2) technical considerations of MCDA tool; (3) development and customization of MCDA tool and (4) policy implementation of MCDA in decision-making. Expert commentary: These practical MCDA recommendations for developing countries contribute to feasible, transparent, stepwise, iterative and standardized decision-making in health care.",
    keywords = "Decision Making, Developing Countries, Implementation Guidance, Multiple Criteria Decision Analysis, Off-patent Pharmaceuticals",
    author = "Andr{\'a}s Inotai and Nguyen, {Huong Thanh} and Budi Hidayat and Talgat Nurgozhin and Kiet, {Pham Huy Tuan} and Campbell, {Jonathan D.} and Bertalan N{\'e}meth and Nikos Maniadakis and Diana Brixner and Kalman Wijaya and Zolt{\'a}n Kal{\'o}",
    year = "2018",
    month = "11",
    day = "2",
    doi = "10.1080/14737167.2018.1508345",
    language = "English",
    volume = "18",
    pages = "585--592",
    journal = "Expert Review of Pharmacoeconomics and Outcomes Research",
    issn = "1473-7167",
    publisher = "Expert Reviews Ltd.",
    number = "6",

    }

    TY - JOUR

    T1 - Guidance toward the implementation of multicriteria decision analysis framework in developing countries

    AU - Inotai, András

    AU - Nguyen, Huong Thanh

    AU - Hidayat, Budi

    AU - Nurgozhin, Talgat

    AU - Kiet, Pham Huy Tuan

    AU - Campbell, Jonathan D.

    AU - Németh, Bertalan

    AU - Maniadakis, Nikos

    AU - Brixner, Diana

    AU - Wijaya, Kalman

    AU - Kaló, Zoltán

    PY - 2018/11/2

    Y1 - 2018/11/2

    N2 - Introduction: Multiple Criteria Decision Analysis (MCDA) is increasingly used in health care mainly because it moves decision-making from ad hoc to an evidence-based and comprehensive process. Developing countries with more restricted financial and human research capacities, however, should consider their own methods of MCDA development and implementation. Areas covered: An MCDA framework to improve procurement decisions of off-patent pharmaceuticals was developed for developing countries and adapted to Indonesia, Kazakhstan and Vietnam during three policy workshops. Based on the experience of these workshops and one joint workshop with international experts and decision makers from multiple developing countries, general recommendations were formulated on how to implement MCDA specifically in developing countries. We provide 17 practical MCDA implementation recommendations in four major areas, including (1) MCDA objectives; (2) technical considerations of MCDA tool; (3) development and customization of MCDA tool and (4) policy implementation of MCDA in decision-making. Expert commentary: These practical MCDA recommendations for developing countries contribute to feasible, transparent, stepwise, iterative and standardized decision-making in health care.

    AB - Introduction: Multiple Criteria Decision Analysis (MCDA) is increasingly used in health care mainly because it moves decision-making from ad hoc to an evidence-based and comprehensive process. Developing countries with more restricted financial and human research capacities, however, should consider their own methods of MCDA development and implementation. Areas covered: An MCDA framework to improve procurement decisions of off-patent pharmaceuticals was developed for developing countries and adapted to Indonesia, Kazakhstan and Vietnam during three policy workshops. Based on the experience of these workshops and one joint workshop with international experts and decision makers from multiple developing countries, general recommendations were formulated on how to implement MCDA specifically in developing countries. We provide 17 practical MCDA implementation recommendations in four major areas, including (1) MCDA objectives; (2) technical considerations of MCDA tool; (3) development and customization of MCDA tool and (4) policy implementation of MCDA in decision-making. Expert commentary: These practical MCDA recommendations for developing countries contribute to feasible, transparent, stepwise, iterative and standardized decision-making in health care.

    KW - Decision Making

    KW - Developing Countries

    KW - Implementation Guidance

    KW - Multiple Criteria Decision Analysis

    KW - Off-patent Pharmaceuticals

    UR - http://www.scopus.com/inward/record.url?scp=85052302223&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85052302223&partnerID=8YFLogxK

    U2 - 10.1080/14737167.2018.1508345

    DO - 10.1080/14737167.2018.1508345

    M3 - Article

    VL - 18

    SP - 585

    EP - 592

    JO - Expert Review of Pharmacoeconomics and Outcomes Research

    JF - Expert Review of Pharmacoeconomics and Outcomes Research

    SN - 1473-7167

    IS - 6

    ER -